Tribunal grants joint application for Scheme of Arrangement under Companies Act The Tribunal granted the joint application of the Applicant Companies under Sections 230 to 232 of the Companies Act, 2013, dispensing with meetings of ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Tribunal grants joint application for Scheme of Arrangement under Companies Act
The Tribunal granted the joint application of the Applicant Companies under Sections 230 to 232 of the Companies Act, 2013, dispensing with meetings of shareholders and creditors for the proposed Scheme of Arrangement. Both the Demerged Company and Resulting Company fulfilled the necessary criteria, including obtaining consents from shareholders and creditors, submitting board resolutions, financial statements, and complying with accounting standards. Consequently, the Tribunal issued directions allowing for the dispensation of meetings, considering all approvals and consents were in order.
Issues: Dispensing with meetings of shareholders and creditors for proposed Scheme of Arrangement under Sections 230 to 232 of the Companies Act, 2013.
Analysis: 1. Background and Jurisdiction: The application was jointly filed by the Applicant Companies seeking orders under relevant sections of the Companies Act, 2013 for dispensing with meetings of shareholders and creditors in connection with the proposed Scheme of Arrangement. The companies' registered offices are in New Delhi, falling under the jurisdiction of the Bench.
2. Demerged Company Details: M/s. RAS Life Sciences Private Limited, the Demerged Company, was incorporated in 2008. The company's history of office location shifts was detailed, highlighting its current structure and operations as per the Memorandum of Association.
3. Demerged Company's Financials and Creditors: The Demerged Company has two Equity Shareholders and twenty-four unsecured creditors. The consent affidavits of shareholders and creditors were presented, fulfilling the necessary criteria under Section 230(9) of the Act, allowing for dispensation of meetings.
4. Resulting Company Details: M/s. Biomerieux India Private Limited, the Resulting Company, was incorporated in 1998, with detailed information on its share capital and operations as per the Memorandum of Association.
5. Resulting Company's Shareholders and Creditors: The Resulting Company has two Equity Shareholders and forty-three unsecured creditors. The secured creditor and unsecured creditors' consent affidavits were provided, meeting the requirements for dispensing with meetings.
6. Board Approval and Financial Documents: Board resolutions of both companies approving the Scheme, along with financial statements and compliance with accounting standards, were submitted, ensuring transparency and legality.
7. Directions and Decision: After reviewing the application and documents, the Tribunal issued directions for dispensing with meetings of shareholders and creditors for both companies, as all necessary consents and approvals were obtained, leading to the allowance of the joint application.
This detailed analysis covers the key aspects of the judgment, including company details, financials, creditor consents, compliance, and the final decision of the Tribunal to dispense with the meetings as requested by the Applicant Companies.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.